Find a Trial

Filters

Ovarian phase 2 Accepting New Patients
A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Principal Investigator: Michelle Rowland MD PhD MPH
Clinical Research Coordinator: Lisa Gale MSN RN CCRC
Clinicaltrials.gov Identifier: NCT06890338

Learn More I'm Interested
Lung phase 1 Accepting New Patients
A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-8520 in Subjects With Advanced KRASG12C Mutant Non-Small Cell Lung Cancer - The ONKORAS-101 Study

Principal Investigator: Jun Zhang MD PhD
Clinical Research Coordinator: Vishnu JaiShree Mohandas MBBS MPH
Clinicaltrials.gov Identifier: NCT06343402

Learn More I'm Interested
Lung phase 1 Accepting New Patients
Study of NMS-03305293, a Non-Trapping PARP1-Specific PARP Inhibitor in Relapsed Small Cell Lung Cancer

Principal Investigator: Jun Zhang MD PhD
Clinical Research Coordinator: Vishnu JaiShree Mohandas MBBS MPH
Clinicaltrials.gov Identifier: NCT06931626

Learn More I'm Interested
Lung phase 1 Accepting New Patients
A Phase 1b, Two-Part Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

Principal Investigator: Jun Zhang MD PhD
Clinical Research Coordinator: Vishnu JaiShree Mohandas MBBS MPH
Clinicaltrials.gov Identifier: NCT07027514

Learn More I'm Interested
Cervical phase 4 Accepting New Patients
A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER

Principal Investigator: Michelle Rowland MD PhD MPH
Clinical Research Coordinator: Lisa Gale MSN RN CCRC
Clinicaltrials.gov Identifier: NCT06952660

Learn More I'm Interested
Lung phase 3 Accepting New Patients
A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer

Principal Investigator: Jun Zhang MD PhD
Clinical Research Coordinator: Vishnu JaiShree Mohandas MBBS MPH
Clinicaltrials.gov Identifier: NCT07218146

Learn More I'm Interested
Ovarian phase 1 Accepting New Patients
Study of NMS-03305293, a Non-Trapping PARP1-Specific PARP Inhibitor in Relapsed Ovarian Cancer

Principal Investigator: Michelle Rowland MD PhD MPH
Clinical Research Coordinator: Lisa Gale MSN RN CCRC
Clinicaltrials.gov Identifier: NCT06930755

Learn More I'm Interested
Endometrial phase 3 Accepting New Patients
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (Bluestar-Endometrial01)

Principal Investigator: Michelle Rowland MD PhD MPH
Clinical Research Coordinator: Lisa Gale MSN RN CCRC
Clinicaltrials.gov Identifier: NCT07044336

Learn More I'm Interested

Sorry, we couldn’t find any results that match your search.